Christ SM, Heesen P, Muehlematter UJ, Pohl K, William Thiel G, Willmann J, et al. Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards. Clin Transl Radiat Oncol. 2023;38:123–9.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21:e18-28.
Rees M, Tekkis PP, Welsh FKS, O’Rourke T, John TG. Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer. Ann Surg. 2008;247:125–35.
Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–82.
Article PubMed CAS Google Scholar
Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget. 2015;6:8491–524.
Article PubMed PubMed Central Google Scholar
Manabe Y, Shibamoto Y, Baba F, Murata R, Yanagi T, Hashizume C, et al. Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer. Pract Radiat Oncol. 2012;2:e137–43.
Huang F, Wu G, Yang K. Oligometastasis and oligo-recurrence: more than a mirage. Radiat Oncol. 2014;9:230.
Article PubMed PubMed Central Google Scholar
Autrusseau P-A, Cazzato RL, Koch G, Ramamurthy N, Auloge P, De Marini P, et al. Freezing Nodal Disease: Local Control Following Percutaneous Image-Guided Cryoablation of Locoregional and Distant Lymph Node Oligometastases: A 10-Year, Single-Center Experience. J Vasc Interv Radiol. 2021;32:1435–44.
Tsoumakidou G, Mandralis K, Hocquelet A, Duran R, Denys A. Salvage Lymph-Node Percutaneous Cryoablation: Safety Profile and Oncologic Outcomes. Cardiovasc Intervent Radiol. 2020;43:264–72.
Filippiadis D, Charalampopoulos G, Tsochatzis A, Reppas L, Mazioti A, Kelekis A, et al. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center’s experience. Br J Radiol. 2021;94:20200445.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:n71.
Higgins, J.P.T.: Thomas, J.: Chandler, J.: Cumpston, M.: Li, T.: Page, M.J.: Welch, V.A. (Eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023). Cochrane. 2023. Available online: www.training.cochrane.org/handbook. Accessed on 30 November 2023.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919. https://doi.org/10.1136/bmj.i4919
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
Article PubMed PubMed Central Google Scholar
Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7:55–79.
Chen Y, Chen D, Wang Y, Han Y. Using Freeman-Tukey Double Arcsine Transformation in Meta-analysis of Single Proportions. Aesthetic Plast Surg. 2023;47:83–4.
Fletcher J. What is heterogeneity and is it important? BMJ. 2007;334:94–6.
Article PubMed PubMed Central Google Scholar
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. 2019;22:153–60.
Article PubMed PubMed Central Google Scholar
Hiraki T, Yasui K, Mimura H, Gobara H, Mukai T, Hase S, et al. Radiofrequency Ablation of Metastatic Mediastinal Lymph Nodes during Cooling and Temperature Monitoring of the Tracheal Mucosa to Prevent Thermal Tracheal Damage: Initial Experience. Radiology. 2005;237:1068–74.
Gao F, Gu Y, Huang J, Zhao M, Wu P. Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma. Acad Radiol. 2012;19:1035–40.
Pan T, Xie Q-K, Lv N, Li X-S, Mu L-W, Wu P-H, et al. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score–matching Analysis. Radiology. 2017;282:259–70.
Parvinian A, Schmitz JJ, Welch BT, Atwell TD, Morris JM, Woodrum DA, et al. A Single-Institution Experience in Percutaneous Image-Guided Cryoablation of Lymph Node Metastases. Am J Roentgenol. 2021;217:152–6.
Filippiadis DK, Pua U, Georgiadi E, Quek LHH, Kelekis A, How GY, et al. Percutaneous Ablation of Metastatic Lymph Nodes: An Insight from the Comparison of Efficacy and Safety Between Cryoablation and Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2022;45:1134–40.
Mu L, Sun L, Pan T, Lyu N, Li S, Li X, et al. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results. Int J Hyperth. 2018;34:59–67.
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.
Article PubMed CAS Google Scholar
Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, et al. Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer. JAMA Oncol. 2018;4:e173501.
Ruers T, Van Coevorden F, Punt CJA, Pierie J-PEN, Borel-Rinkes I, Ledermann JA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. JNCI: J Natl Cancer Inst. 2017;109:djx015.
Article PubMed PubMed Central Google Scholar
Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019;37:1558–65.
Article PubMed PubMed Central CAS Google Scholar
Ding Z, Chen J, Chen Z, Zeng X, Zheng P, Wang X, et al. Efficacy and Safety of Thermal Ablation for Treating Lymph Node Metastasis From Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol. 2022;12:738299.
Article PubMed PubMed Central CAS Google Scholar
Franzese C, Badalamenti M, Comito T, Franceschini D, Clerici E, Navarria P, et al. Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment’s intensification? Radiother Oncol. 2020;150:184–90.
Article PubMed CAS Google Scholar
Zeng Z-C, Tang Z-Y, Fan J, Qin L-X, Ye S-L, Zhou J, et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: Retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys. 2005;63:1067–76.
Russell CM, Espiritu PN, Kassouf W, Schwaab T, Buethe DD, Dhilon J, et al. Surgical Outcomes in the Management of Isolated Nodal Recurrences: A Multicenter, International Retrospective Cohort. J Urol. 2014;192:350–6.
MacDermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol. 2008;98:202–6.
Iezzi R, Gangi A, Posa A, Pua U, Liang P, Santos E, et al. Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments. Cancers (Basel). 2023;15:308.
留言 (0)